Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Bio-Rad Laboratories, Inc. logo

Bio-Rad Laboratories, Inc.



Optionable: No  Market Cap: 9,655 M  90-day average vol: 295

Previous close: 279.91  Open: 281.55  Bid:   Ask:
52 week range    
PKI / 
TMO / 
BDX / 
A / 
GE / 
DHR / 
Last updated: Monday 22nd April 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord



StockDividendMarket Cap (B)PEPrice ($)


0.00643 B35.5140.37


0.012972 B37269.27


0.0029205 B33.2285.15


0.0032108 B-15.299.9


0 B-131.86.01


0.0247450 B22.1171.06


0.001522 B17.1182.49


0.0017234 B27587.05

BIO.B Income Statement

AcquiredInProcessRnDIncome1 M
Amortization of intangibles-48 M-36 M-35 M-31 M-28 M-23 M-27 M347 M406 M414 M
Basic EPS from continuing operations142.33-121.79-21.82
Basic EPS total3.083.870.884.1212.2558.93127.86142.33-121.79-21.82
Basic weighted shares outstanding29 M29 M29 M30 M30 M30 M30 M30 M30 M29 M
Cost of sales997 M898 M930 M972 M1,066 M1,055 M1,108 M1,284 M1,235 M1,244 M
Depreciation-150 M-132 M-143 M-149 M-138 M-134 M-138 M138 M137 M146 M
Depreciation unreconciled-40 M-37 M
DepreciationAndAmortization-150 M-132 M-143 M-149 M-138 M-40 M-37 M138 M137 M146 M
Diluted EPS total3.053.850.884.0712.158.27126.2140.56-121.79-21.82
Diluted normalized net income/share140.56-121.79-21.82
Diluted weighted shares outstanding29 M29 M30 M30 M30 M30 M30 M30 M30 M29 M
GainOnSaleOfBusiness-400000.0-1 M-900000.01 M-1 M-2 M
GainOnSaleOfPPE-400000.0-300000.0-600000.0-8 M5 M12 M1 M
GainOnSaleOfSecurity15 M2 M800000.07 M606 M2,031 M4,496 M8 M2 M700000.0
GeneralAndAdministrativeExpense-47 M-45 M-44 M-44 M-47 M877 M828 M842 M
Gross operating profit1,179 M1,122 M1,138 M-972 M-1,066 M-1,055 M1,438 M1,638 M1,567 M1,427 M
ImpairmentOfCapitalAssets-6 M62 M12 M293 M
Income before tax132 M146 M42 M98 M513 M2,261 M4,908 M5,449 M-4,704 M-850 M
Income restructuring and M&A-12 M-11 M4 M28 M
Income taxes43 M33 M16 M-24 M147 M502 M1,101 M1,195 M-1,077 M-213 M
InterestExpenseNonOperating22 M22 M22 M23 M24 M23 M22 M2 M38 M49 M
MiscOtherSpecialCharges13 M11 M15 M2,171 M2,326 M2,338 M2,570 M27 M45 M106 M
Net income from total operations89 M113 M26 M122 M366 M1,759 M3,806 M4,254 M-3,627 M-637 M
NetIncomeCommonStockholders90 M113 M26 M122 M366 M1,759 M3,806 M4,254 M-3,627 M-637 M
NetIncomeContinuousOperations89 M113 M26 M122 M366 M1,759 M3,806 M4,254 M-3,627 M-637 M
NetNonOperatingInterestIncomeExpense-22 M-22 M-22 M-23 M-24 M-23 M-22 M-2 M-38 M-49 M
NonRecurringOperationExpense-20 M-141608.0-141608.0-141608.0-35 M
Normalized income-1,051 M
Operating income150 M167 M115 M-2,029 M-2,100 M-2,082 M-2,135 M500 M483 M338 M
Operating income before depreciation (EBITDA)154 M168 M64 M121 M537 M2,244 M4,892 M5,451 M-4,666 M-801 M
OperatingExpense1,029 M955 M1,023 M1,057 M1,034 M1,027 M1,027 M1,138 M1,085 M1,089 M
Other income net-29 M-11 M-15 M-2,171 M-2,932 M-4,369 M-7,066 M-4,953 M5,149 M1,146 M
OtherGandA-47 M-45 M-44 M-44 M-47 M877 M828 M842 M
OtherImpairmentOfCapitalAssets-46 M-7 M-800000.0-6 M-5 M800000.012 M
OtherOperatingExpenses-2 M-1 M-3 M-35 M-5 M-51 M-45 M-18 M-10 M-12 M
OtherWriteOff-7 M-2 M-1 M-2 M-600000.0
RentAndLandingFees-47 M-45 M-44 M-44 M-47 M
Research & development expense220 M193 M206 M250 M199 M203 M227 M261 M257 M247 M
ResearchExpense220 M193 M206 M250 M199 M203 M227 M261 M257 M247 M
RestructringAndMnAIncome-12 M-11 M4 M28 M
Revenue per share-48 M-36 M-33 M-29 M-27 M-24 M-29 M346 M407 M414 M
SalariesAndWages-15 M-17 M-20 M-23 M-28 M-36 M-42 M-7 M-9 M-10 M
Selling Gen & administrative expense808 M762 M817 M807 M835 M825 M800 M877 M828 M842 M
SellingAndMarketingExpense808 M762 M817 M807 M835 M825 M800 M
SellingExpense808 M762 M817 M807 M835 M825 M800 M
Special income/charges6 M-62 M-12 M-293 M35 M11 M-4 M-28 M
Total Income available for interest expense (EBIT)154 M168 M64 M121 M537 M2,284 M4,929 M5,451 M-4,666 M-801 M
Total common shares outstanding29 M29 M30 M30 M30 M30 M30 M30 M30 M29 M
Total net income89 M113 M26 M122 M366 M1,759 M3,806 M4,254 M-3,627 M-637 M
Total ordinary shares5 M5 M5 M5 M5 M5 M5 M5 M5 M5 M
Total revenues2,175 M2,019 M2,068 M2,160 M2,289 M2,312 M2,546 M2,923 M2,802 M2,671 M
TotalExpenses2,025 M1,853 M1,953 M2,029 M2,100 M2,082 M2,135 M2,422 M2,320 M2,333 M
TotalRevenue2,175 M2,019 M2,068 M2,160 M2,289 M2,312 M2,546 M2,923 M2,802 M2,671 M
WriteDown-1 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu


I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.


Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University